MARK GILLEN: Open Payments
NPI 1609833078 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 20 payments from 6 companies in 2025. Trend: 2023 $37 · 2024 $231 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $303 |
| PFIZER INC. | 3 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $22 |
| Dynavax Technologies Corporation | 1 | $21 |
| Lilly USA, LLC | 1 | $17 |
Products named: AIRSUPRA, PAXLOVID, XIFAXAN, ZORYVE, Heplisav-B, MOUNJARO.
Industry payments across OK — which companies pay providers there.
